![Francis Duhay](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 25 297 $ al 30/06/2026
Francis Duhay is the founder of Kahala Biosciences LLC, Makani Science, Inc., KOA Accel LLC.
Current jobs include Chief Executive Officer at Kino Discovery, Inc., Independent Director at enVVeno Medical Corp.
since 2018, and Partner at K5 Ventures LLC since 2017.
Former jobs include Chief Executive Officer & Director at Microdermics, Inc., Chief Medical Officer & VP-Global Clinical Affairs at Edwards Lifesciences Corp.
from 2012 to 2017, President & Chief Operating Officer at Aegis Surgical, Inc., President & Chief Operating Officer at Atrius, Inc., and Senior VP-Global Medical & Clinical Affairs at Olympus Corp.
from 2020 to 2022.
Education includes graduate studies at The University of California, San Francisco, and an MBA from Shidler College of Business.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 11/06/2026 | 2.362 ( 0,35 % ) | 25 297 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ENVVENO MEDICAL CORPORATION | Director/Miembro de la Junta | 02/10/2018 |
K5 Ventures LLC
 K5 Ventures LLC Investment ManagersFinance K5 Ventures invests in companies located in the United States, primarily in Southern California and Asia. The firm focuses on the technology service. It provides financing for early and later stage capital requirements. | Inversor de Capital Privado | 01/01/2017 |
KOA Accel LLC
 KOA Accel LLC Investment ManagersFinance KOA Accel invests in private companies located in the United States. The firm focuses on the sector of health technology. It participates in pre-seed to early stage transactions with an investment size of USD 0.5 million. | Director Ejecutivo | - |
Kino Discovery, Inc.
 Kino Discovery, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices | Director Ejecutivo | - |
| Empresas | Cargo | Fin |
|---|---|---|
| OLYMPUS CORPORATION | Director Técnico/Científico/I+D | 01/10/2022 |
| EDWARDS LIFESCIENCES CORPORATION | Director Técnico/Científico/I+D | 01/06/2017 |
Kahala Biosciences LLC
 Kahala Biosciences LLC Miscellaneous Commercial ServicesCommercial Services Offers subscription-based COVID testing plans for commercial, industrial and corporate clients | Fundador | - |
Makani Science, Inc.
 Makani Science, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops respiratory monitoring devices | Director Ejecutivo | - |
Microdermics, Inc.
 Microdermics, Inc. Medical SpecialtiesHealth Technology Develops novel hollow microneedles | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 13 |
|---|---|
Edwards Lifesciences Corp.
 Edwards Lifesciences Corp. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets products to treat late-stage cardiovascular disease | Health Technology |
Olympus Corp.
 Olympus Corp. Medical SpecialtiesHealth Technology Manufactures and sells precision machineries and instruments | Health Technology |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
enVVeno Medical Corp.
 enVVeno Medical Corp. Medical SpecialtiesHealth Technology Specializes in biological cardiovascular implants | Health Technology |
Shidler College of Business
 Shidler College of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
K5 Ventures LLC
K5 Ventures LLC Investment ManagersFinance K5 Ventures invests in companies located in the United States, primarily in Southern California and Asia. The firm focuses on the technology service. It provides financing for early and later stage capital requirements. | Finance |
Microdermics, Inc.
Microdermics, Inc. Medical SpecialtiesHealth Technology Develops novel hollow microneedles | Health Technology |
Aegis Surgical, Inc.
 Aegis Surgical, Inc. Medical SpecialtiesHealth Technology Develops medical technology designed to offer access and treatment of symptomatic aortic stenosis | Health Technology |
Atrius, Inc.
 Atrius, Inc. Packaged SoftwareTechnology Services Provides software solutions for buildings | Technology Services |
Makani Science, Inc.
Makani Science, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops respiratory monitoring devices | Electronic Technology |
KOA Accel LLC
KOA Accel LLC Investment ManagersFinance KOA Accel invests in private companies located in the United States. The firm focuses on the sector of health technology. It participates in pre-seed to early stage transactions with an investment size of USD 0.5 million. | Finance |
Kahala Biosciences LLC
Kahala Biosciences LLC Miscellaneous Commercial ServicesCommercial Services Offers subscription-based COVID testing plans for commercial, industrial and corporate clients | Commercial Services |
Kino Discovery, Inc.
Kino Discovery, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
